LTZ Therapeutics

LTZ Therapeutics Inc., a biotechnology company specializing in immunotherapy with operations in both the US and China, has reportedly raised more than USD 20 million in a Series A financing round. The funding round was led by Lapam Capital, with participation from GL Ventures as well as existing investors Qiming…